Stromelysin (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase (TIMP-1) mRNA expression in scleritis

References

• McCluskey P, Wakefield D. Prediction of response to treatment in patients with scleritis using a standardised scoring system. Aust NZ J Ophthalmol 1991; 19: 211–215
   PubMedGoogle Scholar
• Wakefield D, McCluskey P. Cyclosporin therapy for severe scleritis. Br J Ophthalmol 1989; 73: 743–746
   PubMed Web of Science ®Google Scholar
• McCarthy M J, Dubord P J, Chalmers A, Kassen B O, Rangno K K. Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis. J Rheumatol 1992; 19: 1358–1361
   PubMed Web of Science ®Google Scholar
• Gravallese E M, Darling J M, Ladd A -L, Glimcher L H. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthr Rheumatol 1991; 34: 1076–1084
   PubMed Web of Science ®Google Scholar
• Firestein G S. Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis. Curr Opin Rheumatol 1992; 4: 348–354
   PubMedGoogle Scholar
• Murphy G, Cartwright E C, Sellers A, Reynolds J J. The detection and characterization of collagenase inhibitors from rabbit tissue in culture. Biochim Biophys Acta 1977; 483: 493–498
   PubMed Web of Science ®Google Scholar
• Cawston T E, Galloway W A, Mercer E, Murphy G, Reynolds J J. Purification of rabbit bone inhibitor of collagenase. Biochem J 1981; 195: 159–165
   PubMed Web of Science ®Google Scholar
• Matrisian L M. Metalloproteinase and their inhibitors in matrix remodelling. Trend Genet 1990; 6: 121–125
   PubMed Web of Science ®Google Scholar
• Edmonard H, Grimaud J -A. Matrix metalloproteinases. A review. Cell Mol Biol 1990; 36: 131–153
   PubMed Web of Science ®Google Scholar
• Matrisian L M. The matrix degrading metalloproteinases. Bio Essays 1992; 14: 455–463
   PubMed Web of Science ®Google Scholar
• Woessner J F. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991; 5: 2145–2154
   PubMed Web of Science ®Google Scholar
• Khokha R, Denhardt D T. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigenesis and tissue invasion. Invasion Metastasis 1989; 9: 391–405
   PubMedGoogle Scholar
• Overall C M, Wrana J L, Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-B 1 in human fibroblasts. J Biol Chem 1991; 266: 14064–14071
   PubMed Web of Science ®Google Scholar
• Mauniel A, Kahari V -M, Kurkinen M, Evans C H, Vitto J. Leukoregulina T-cell derived cytokine, upregulates stromelysin-1 gene expression in dermal fibroblasts: Evidence for the role of AP-1 in transcriptional activation. J Cell Biochem 1992; 50: 53–61
   PubMed Web of Science ®Google Scholar
• Hutchinson N I, Lark M W, MacNaul K L, Harper C, Hoerrner L A, McDonnell J, et al. In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1B. Arthr Rheumatol 1992; 35: 1227–1233
   PubMed Web of Science ®Google Scholar
• Van der Zee E, Everts V, Hoeben K, Beertsen W. Interleukin-1α and epidermal growth factor synergistically enhance the release of collagenase by periosteal connective tissue in vitro. Matrix 1993; 13: 389–398
   PubMedGoogle Scholar
• Hunt R C, Fox A, Pakalnis V A, Sigel M M, Kosnosky W, Choudhury P, Black P E. Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels. Invest Ophthalmol Vis Sci 1993; 34: 3179–3186
   PubMed Web of Science ®Google Scholar
• Girard M T, Matsubara M, Fini M E. Transforming growth factor-B and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991; 32: 2441–2454
   PubMed Web of Science ®Google Scholar
• MacNaul K L, Chartrain N, Lark M, Tocci M J, Hutchinson N J. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase in rheumatoid human synovial fibroblasts. J Biol Chem 1991; 265: 17238–17245
   Web of Science ®Google Scholar
• Bucala R, Ritchlin C, Winchester R, Cerami A. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 1991; 173: 569–574
   PubMed Web of Science ®Google Scholar
• Firestein G S, Paine M M. Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 1992; 140: 1309–1314
   PubMed Web of Science ®Google Scholar
• Crabb I D, Hughes S S, Hicks D G, Pozas J E, Tsao G JY, Rosier R N. Non radioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Am J Pathol 1992; 141: 579–589
   PubMed Web of Science ®Google Scholar
• Harrison S A, Mondino B J, Mayer F J. Scleral fibroblasts; Human leukocyte antigen expression and complement production. Invest Ophthalmol Vis Sci 1990; 31: 2412–2419
   PubMed Web of Science ®Google Scholar
• Hoyhtya M, Myllyla R, Piuva J, Kivirikko K I, Tryggvason K. Monoclonal antibodies to human prolyl 4-hydroxylase. Eur J Biochem 1984; 141: 477–482
   Google Scholar
• Chomezynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Maniatis T E, Fritsch E F, Sambrook J. Molecular cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1982
   Google Scholar
• Burnette W N. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112: 195–203
   PubMed Web of Science ®Google Scholar
• Dean D D, Pelletier-Martel J, Pellier J -P, Howell D S, Woessner J F. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989; 84: 678–685
   PubMed Web of Science ®Google Scholar
• Pelletier J -P, Mineau F, Faure M -P, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteinases in the early lesions of experimental osteoarthritis. Arthr Rheumatol 1990; 33: 1466–1476
   PubMed Web of Science ®Google Scholar
• Ponton A, Coulombe B, Skup D. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res 1991; 51: 2138–2143
   PubMed Web of Science ®Google Scholar
• Vance B A, Kowalski C G, Brinkerhoff C E. Heat shock of rabbit synovial fibroblasts increases expression of mRNA for two metalloproteinases, collagenase and stromelysin. J Cell Biol 1989; 108: 2037–2043
   PubMed Web of Science ®Google Scholar
• Frish S M, Clark E J, Werb Z. Coordinate regulation of stromelysin and collagenase genes determined with cDNA probes. Proc Natl Acad Sci USA 1987; 84: 2600–2604
   PubMed Web of Science ®Google Scholar
• Matsubara M, Girard M T, Kubin C L, Cintron C, Fini M E. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Devel Biol 1991; 147: 425–439
   PubMed Web of Science ®Google Scholar
• Fini M E, Yue B, Sugar J. Collagenolytic/gelatinolytic metalloproteinase in normal and keratoconus corneas. Curr Eye Res 1992; 11: 849–862
   PubMed Web of Science ®Google Scholar
• Brown D, Chwa M, Escobar M, Kenney M C. Characterization of the major matrix degrading metalloproteinases of the human corneal stroma. Evidence for an enzyme/inhibitor complex. Exp Eye Res 1991; 52: 5–16
   PubMed Web of Science ®Google Scholar
• Ando H, Twining S S, Yue B, Zhou X, Fini M E, Kaiya T, et al. MMPs and proteinase inhibitors in the human aqueous humor. Invest Ophthalmol Vis Sci 1993; 34: 3541–3548
   PubMed Web of Science ®Google Scholar
• Shapiro S D, Campbell E J, Kobayashi D K, Welgus H G. Immune modulation of metalloproteinase production in human macrophages. J Clin Invest 1990; 86: 1204–1210
   PubMed Web of Science ®Google Scholar